<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02791295</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A00481-50</org_study_id>
    <nct_id>NCT02791295</nct_id>
  </id_info>
  <brief_title>Lifestyle Intervention in Type 2 Diabetes</brief_title>
  <acronym>WeightPump</acronym>
  <official_title>Diet and Physical Activity Lifestyle Intervention to Prevent Body Weight Gain in Patients With Type 2 Diabetes Starting Insulin Pump Treatment: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icadom</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AGIR à Dom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Icadom</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether a personalized lifestyle intervention
      focused on diet and physical activity reinforcement is effective in avoiding weight gain in
      the first months following initiation of subcutaneous insulin pump therapy in type-2 diabetic
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with type 2 diabetes using insulin pump therapy are gaining weight within the first
      months of treatment. This weight gain could counterbalance the metabolic benefice of insulin
      pump treatment in improving glycemic control and could lead to treatment dropout. Lifestyle
      intervention aiming at improving physical activity and diet in type 2 diabetes is known to
      brought body weight reduction and cardiometabolic improvement.

      The investigator hypothesized that an intensive, home-based, 6-months diet and physical
      activity program could prevent the body weight gain associated with insulin pump treatment
      initiation. The investigator will randomize patients with type 2 diabetes into a &quot;lifestyle
      intervention&quot; arm or a &quot;usual care&quot; control arm at the time of insulin pump treatment
      initiation. The primary objective will evaluate body weight change at 6 months after insulin
      pump treatment initiation. The secondary objectives will evaluate change in glycemic control
      (HbA1c) and body composition at 6 months. In addition, the retention effect will be assessed
      on body weight change one year after insulin pump treatment initiation, 6 months after the
      end of the lifestyle intervention.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 4, 2016</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight change</measure>
    <time_frame>6 months</time_frame>
    <description>The difference in body weight changes between the two groups over a six-month period following initiation of insulin pump treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>6 months</time_frame>
    <description>The difference in HbA1c changes between the two groups after 6-months of insulin pump treatment initiation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>6 months</time_frame>
    <description>The difference between the two groups in distribution of fat mass and lean mass between the first visit and 6 months after initiation of insulin pump treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>The difference between the two groups of scores of the Diabetes Treatment Satisfaction Questionnaire between the first visit and 6 months after initiation of insulin pump treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intermediate weight change</measure>
    <time_frame>3 months</time_frame>
    <description>The difference in weight changes between the two groups after 3-months of insulin pump treatment initiation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retention of weight change</measure>
    <time_frame>1 year</time_frame>
    <description>The difference in weight changes between the two groups at 12-months of insulin pump treatment initiation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Type 2 Diabetes Treated With Insulin</condition>
  <arm_group>
    <arm_group_label>Diet and physical activity program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diet and physical activity program with individual coaching</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet and physical activity program</intervention_name>
    <description>A personalized intervention focused on improving diet and increasing physical activity will be implemented at-home with a monthly support by a registered dietician and physical activity educator during 6 months</description>
    <arm_group_label>Diet and physical activity program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult Type 2 diabetic patients with indication of initiation of insulin pump therapy.

          -  Patients addressed for the insulin pump follow-up to the home care provider supporting
             the study.

          -  Public health care security affiliation.

        Exclusion Criteria:

          -  Breastfeeding or pregnant woman.

          -  Not willing to participate as assessed by the investigator.

          -  Patient engaged in another clinical trial with exclusion criteria for other protocol.

          -  Patients unable to ride a training bike.

          -  Unavailable in the next 6 months.

          -  Patient without a medical certificate done in the last 12 months by a cardiologist
             attesting the ability to participate in a physical activity reinforcement program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Laure Borel, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Borges</last_name>
    <phone>+33 476510304</phone>
    <email>l.borges@agiradom.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Christian Borel, PhD</last_name>
    <phone>+33 762707821</phone>
    <email>j.borel@agiradom.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Annecy-Genevois Hospital</name>
      <address>
        <city>Annecy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hafid Amougay, MD</last_name>
      <phone>+33 450636363</phone>
      <email>hamougay@ch-annecygenevois.fr</email>
    </contact>
    <investigator>
      <last_name>Hafid Amougay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marlène Rousset, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pierre Oudot Hospital</name>
      <address>
        <city>Bourgoin-Jallieu</city>
        <zip>38302</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hala Rachidi-Koussa, MD</last_name>
      <phone>+33 469157343</phone>
      <email>hrachidi@ch-bourguoin.fr</email>
    </contact>
    <investigator>
      <last_name>Hala Rachidi-Koussa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra Crand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Métropole Savoie Hospital</name>
      <address>
        <city>Chambéry</city>
        <zip>73000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène Du-Boullay, MD</last_name>
      <phone>+33 0479965094</phone>
      <email>helene.du-boullay@ch-metropole-savoie.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène Du-Boullay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alpes Léman Hospital</name>
      <address>
        <city>Contamine-sur-Arve</city>
        <zip>74130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Laure Borel, MD PhD</last_name>
      <phone>+33 476765836</phone>
      <email>alborel@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Matthieu Lesgoirres</last_name>
      <email>mlesgoirres@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Sandrine Lablanche, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Yves Benhamou, Pr MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Louis Pépin, Pr MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Doutreleau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marseille European Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Carvalho, MD</last_name>
      <phone>+33 413427000</phone>
      <email>martin.carvalho@orange.fr</email>
    </contact>
    <investigator>
      <last_name>Martin Carvalho, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2016</study_first_submitted>
  <study_first_submitted_qc>June 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2016</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>lifestyle intervention</keyword>
  <keyword>insulin pump treatment</keyword>
  <keyword>body weight</keyword>
  <keyword>body composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

